UI Hospitals and Clinics
The participants in this study have been diagnosed with recurrent osteosarcoma in the lung and have received standard treatments for this type of cancer. The purpose of this research study is to see if participants will benefit from taking a drug called AZD0530. Approximately 5 people will take part in this study conducted by researchers at the University of Iowa. Study involvement will last for approximately 5 years.
Cindy Robertson, 319-356-2778
We welcome your feedback! Please help us improve your experience on our website by completing a brief survey.